We recommend using a newer internet browser, such as Google Chrome or Microsoft Edge, to optimize your browsing experience.

Skip to main content

Actatecan

- Antineoplastic
- Specialty

Product TA: Antineoplastic

Active Ingredient: Irinotecan

Route Of Administration: IV

Product type: Specialty

Product Details

Specialty: Oncology

Strength: 100 mg

Product Form: Vial

Registration Number: DKI1429200249A1

Product Details

Specialty: Oncology

Strength: 40 mg

Product Form: Vial

Additional products

Plaxat

Product TA: Antineoplastic
Active Ingredient: Oxaliplatin
Route Of Administration: IV
Product type: Specialty

Lezra

Product TA: Antineoplastic
Active Ingredient: Letrozole
Route Of Administration: Oral
Product type: Specialty

Page Last Updated: 05 October 2021